Calliditas Financial Statements From 2010 to 2026
Analyzing historical trends in various income statement and balance sheet accounts from Calliditas Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Calliditas Therapeutics' valuation are summarized below:Calliditas Therapeutics does not presently have any fundamental signals for analysis.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Check Calliditas Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calliditas Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Calliditas financial statements analysis is a perfect complement when working with Calliditas Therapeutics Valuation or Volatility modules.
Calliditas |
Calliditas Therapeutics Company Operating Margin Analysis
Calliditas Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Calliditas Therapeutics Operating Margin | (0.06) % |
Most of Calliditas Therapeutics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calliditas Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Calliditas Therapeutics has an Operating Margin of -0.0563%. This is 99.84% lower than that of the Biotechnology sector and 99.95% lower than that of the Health Care industry. The operating margin for all United States stocks is 98.98% lower than that of the firm.
Calliditas Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Calliditas Therapeutics's current stock value. Our valuation model uses many indicators to compare Calliditas Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Calliditas Therapeutics competition to find correlations between indicators driving Calliditas Therapeutics's intrinsic value. More Info.Calliditas Therapeutics is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Calliditas Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Calliditas Stock
If you are still planning to invest in Calliditas Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calliditas Therapeutics' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |